BAYZF
May 13, 2025 - AI Summary
Market cap | $27.70 Billion |
---|---|
Enterprise Value | $63.30 Billion |
Dividend Yield | $- (-%) |
Earnings per Share | $- |
Beta | - |
Outstanding Shares | - |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | - |
---|---|
PEG | - |
Price to Sales | - |
Price to Book Ratio | - |
Enterprise Value to Revenue | 1.36 |
Enterprise Value to EBIT | 167.92 |
Enterprise Value to Net Income | -25 |
Total Debt to Enterprise | 0.66 |
Debt to Equity | 1.31 |
No data
No data
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Ani...